STAAR Surgical (NASDAQ:STAA)’s share price dropped 10% on Monday . The stock traded as low as $36.04 and last traded at $36.40. Approximately 605,600 shares changed hands during trading, an increase of 55% from the average daily volume of 390,419 shares. The stock had previously closed at $40.43.

STAA has been the subject of several research reports. Benchmark reaffirmed a “buy” rating and set a $54.00 price target (up from $45.00) on shares of STAAR Surgical in a research note on Monday, September 24th. BidaskClub cut shares of STAAR Surgical from a “strong-buy” rating to a “buy” rating in a research note on Tuesday. Canaccord Genuity raised their target price on shares of STAAR Surgical from $43.00 to $55.00 and gave the company a “buy” rating in a research note on Friday, September 14th. Finally, Zacks Investment Research raised shares of STAAR Surgical from a “hold” rating to a “strong-buy” rating and set a $51.00 target price for the company in a research note on Thursday, November 8th. Five analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $45.25.

The firm has a market cap of $1.78 billion, a PE ratio of 3,640.50 and a beta of 2.05. The company has a debt-to-equity ratio of 0.01, a current ratio of 5.35 and a quick ratio of 4.76.

STAAR Surgical (NASDAQ:STAA) last posted its earnings results on Wednesday, October 31st. The medical instruments supplier reported $0.03 earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.03) by $0.06. STAAR Surgical had a return on equity of 14.80% and a net margin of 3.17%. The company had revenue of $31.77 million during the quarter, compared to the consensus estimate of $30.10 million. During the same quarter last year, the firm earned $0.03 earnings per share. Equities research analysts predict that STAAR Surgical will post 0.09 earnings per share for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the company. Winslow Evans & Crocker Inc. acquired a new stake in shares of STAAR Surgical during the third quarter worth $142,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of STAAR Surgical during the third quarter worth $222,000. United Services Automobile Association acquired a new stake in shares of STAAR Surgical during the third quarter worth $278,000. Xact Kapitalforvaltning AB acquired a new stake in shares of STAAR Surgical during the third quarter worth $278,000. Finally, Advisors Asset Management Inc. acquired a new stake in shares of STAAR Surgical during the third quarter worth $302,000. 84.11% of the stock is owned by institutional investors.

TRADEMARK VIOLATION WARNING: “STAAR Surgical (STAA) Stock Price Down 10%” was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece can be viewed at https://www.dailypolitical.com/2018/11/20/staar-surgical-staa-stock-price-down-10.html.

STAAR Surgical Company Profile (NASDAQ:STAA)

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.

Featured Story: Google Finance

Receive News & Ratings for STAAR Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STAAR Surgical and related companies with MarketBeat.com's FREE daily email newsletter.